Tag: patent expiration
Future Biosimilars: Upcoming Patent Expirations and Market Entry
Upcoming patent expirations for major biologics like Keytruda and Eylea will trigger a wave of biosimilars, cutting costs and reshaping healthcare. Learn how these complex drugs differ from generics, who's developing them, and what it means for patients and providers.
Future Role of Authorized Generics: Market Outlook
Authorized generics are brand-name drugs sold under a generic label. As patents expire on high-revenue drugs, their role in pricing and competition is shifting - with new FDA policies and domestic manufacturing incentives changing how they’re used.